Jennison Associates’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-957,056
Closed -$37M 670
2017
Q1
$37M Buy
957,056
+71,018
+8% +$2.98M 0.04% 322
2016
Q4
$33.7M Sell
886,038
-85,888
-9% -$4.09M 0.04% 329
2016
Q3
$52.6M Buy
971,926
+7,784
+0.8% +$396K 0.06% 272
2016
Q2
$35.4M Buy
964,142
+375,772
+64% +$13.3M 0.04% 335
2016
Q1
$18.5M Buy
588,370
+11,530
+2% +$399K 0.02% 414
2015
Q4
$35.5M Sell
576,840
-875
-0.2% -$55.3K 0.03% 344
2015
Q3
$40M Buy
+577,715
New +$40.1M 0.04% 339

Other funds holding RDUS

Jennison Associates's RDUS Position: Q2 2017 in Review

Jennison Associates sold out of Radius Health, Inc. (RDUS) in Q2 2017, closing a stake of 957,056 shares — an estimated $37M sold.

Jennison Associates first reported a position in RDUS in Q3 2015 and held it in 7 quarters. The position peaked at $52.6M in Q3 2016. 151 funds tracked by Wall St. Rank hold RDUS as of Q2 2017.

  • Jennison Associates reported no remaining Radius Health, Inc. position as of Q2 2017 after selling out during the quarter.
  • Jennison Associates sold 957,056 Radius Health, Inc. shares in Q2 2017, an estimated $37M.
  • Jennison Associates first reported a position in Radius Health, Inc. in Q3 2015 and held it in 7 quarters.
  • Jennison Associates's Radius Health, Inc. position peaked at $52.6M in Q3 2016.
  • 151 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q2 2017.

Based on Jennison Associates's 13F filing for Q2 2017, filed 4 Aug 2017.